Clover Health Investments, CORP /DE Form 4 insider transactions

Clover Health Investments, Corp. Director Carladenise Edwards sold 67,160 shares of Class A Common Stock on May 18, 2026.

Clover Health Investments Corp. Interim CFO Joseph Clay Thornton reported a transaction involving the sale of Class A Common Stock to cover tax obligations upon restricted stock unit vesting.

Brady Priest, CEO of Clover Care Services, disposed of 98,039 shares of Clover Health Investments, Corp. at a price of $3.52 per share.

Brady Priest, CEO of Clover Care Services, reported the withholding of 36,113 shares to satisfy tax obligations related to RSU vesting.

Brady Priest, CEO of Clover Care Services, reported the withholding of 15,471 shares to cover tax obligations related to RSU vesting.

Chief Legal Officer Karen Soares disposed of 10,161 shares of Clover Health Class A Common Stock to satisfy tax obligations related to RSU vesting.

Clover Health CEO Andrew Toy disposed of 60,765 shares of Class A Common Stock to satisfy tax obligations related to RSU vesting.

Interim CFO Joseph Clay Thornton reported the withholding of 4,158 shares of Class A Common Stock to satisfy tax obligations related to RSU vesting.

Clover Health CEO Jamie Reynoso reported the withholding of 12,712 shares to satisfy tax obligations related to RSU vesting.

Clover Health Investments executive Conrad Wai reported the withholding of 23,463 shares to satisfy tax obligations following an RSU vest.

Clover Health Investments Corp. CEO Jamie L. Reynoso reported the disposition of 6,197 shares of Class A Common Stock to cover tax obligations upon the vesting of restricted stock units.

Brady Patrick Priest, CEO of Clover Care Services, received a significant award of Class A common stock units from Clover Health Investments, Corp.

Clover Health Investments Corp. insider Jamie L. Reynoso reports acquisition of 159,384 Class A common stock shares via restricted stock unit vesting.

Clover Health Investments, Corp. CEO Andrew Toy reported transactions involving Class A Common Stock, including the vesting of restricted stock units and the withholding of shares for tax obligations.

Conrad Wai, CEO of Clover Health Investments, Corp., reported transactions involving restricted stock units and shares held in trust.

Clover Health Investments Corp. Chief Legal Officer Karen Soares acquired 382,522 shares of Class A common stock through a restricted stock unit award.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported a planned sale of 5,833 shares of Class A Common Stock for a weighted average price of $1.91 per share under a pre-arranged 10b5-1 trading plan.

Clover Health CEO Conrad Wai reported a routine disposition of shares to cover tax obligations from RSU vesting.

Clover Health's CEO of Home Care, Brady Priest, reported the sale of 175,000 Class A Common Stock shares for $2.17 per share.

Clover Health CEO Andrew Toy disposed of 85,704 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CFO, Peter J. Kuipers, reported the disposition of 156,856 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health CEO Andrew Toy disposed of 60,764 Class A Common Stock shares on January 15, 2026, to cover tax liabilities from RSU vesting.

Clover Health General Counsel Karen Soares reported the automatic withholding of 11,686 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health CEO Conrad Wai reported a tax withholding of 25,868 shares of Class A Common Stock at $2.81 per share due to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the sale of 4,597 shares and the withholding of 14,732 shares for tax obligations related to RSU vesting.

Clover Health's CEO of Home Care, Brady Priest, disposed of shares to cover tax obligations related to RSU vesting.

Clover Health Investments Director and 10% owner Vivek Garipalli reported the vesting of restricted stock units and subsequent share withholding for tax obligations.

Clover Health Investments director Demetrios L. Kouzoukas was granted 79,365 restricted stock units, vesting on January 6, 2027.

Clover Health Investments Corp. Director Carladenise Armbrister Edwards was granted 79,365 restricted stock units, vesting in one year.

Clover Health Investments Director Anna U. Loengard reported the acquisition of 79,365 restricted stock units and updated her beneficial ownership.